Hi Congo, ignoring big winners new flip flop back to how amazing innate is its worth noting a couple things (sorry for the formatting I'm on mobile). 1) Roche tested it's new drug on patients with spms as well, but it doesn't seem to be effective from what I can tell. 2) Even if it were effective it wouldn't necessarily rule out mis416 being used in combination. 3) patients on roches trial showed increased incidence of cancer, so even if they were competing with mis416 they might end up being a clearly worse option. Anyway, as usual ignore the up and down ramping and wait for the results.
Hi Congo, ignoring big winners new flip flop back to how amazing...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 14.5¢ | $78.75K | 518.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3340 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 97318 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |